Effectiveness of Botulinum Toxin Infiltration for treatment of upper limb dysfunctions after treatment for breast cancer.
- Conditions
- Patients treated for breast cancer and chronic pain (> 3 months) at the breast region
- Registration Number
- NL-OMON26807
- Lead Sponsor
- Z Leuven
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
women after breast cancer with unilateral axillary lymph node dissection or sentinel node biopsy; mastectomy (with or without autologous reconstruction) or wide excision of the tumour
- adjuvant chemotherapy and/or radiotherapy finished for at least 3 months
- Pain at the breast region for at least 3 months
Exclusion Criteria
- Patients with metastasis and patients who cannot participate during the entire study or patients who are mentally or physically not able to participate in the study are excluded
- Cases were no injection is possible in the pectoral muscle (e.g. reconstruction with a tissue expander) are excluded as well.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is the evolution of pain at the breast region.
- Secondary Outcome Measures
Name Time Method - Pain-pressure thresholds of the pectoral muscles and shoulder girdle muscles<br>- Shoulder mobility<br>- Shoulder function<br>- Shoulder alignment<br>- Quality of life<br>